ANGO Valuation

AngioDynamics Inc

Add to Watchlist

Advanced Chart

12.213

-0.088(-0.715%)1D

ANGO Relative Valuation

ANGO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ANGO is overvalued; if below, it's undervalued.

Historical Valuation

AngioDynamics Inc (ANGO) is now in the Overvalued zone, suggesting that its current forward PS ratio of 12.66 is considered Overvalued compared with the five-year average of -98.44. The fair price of AngioDynamics Inc (ANGO) is between 2.99 to 5.11 according to relative valuation methord. Compared to the current price of 12.30 USD , AngioDynamics Inc is Overvalued By 140.64%.

Relative Value

Fair Zone

2.99-5.11

Current Price：12.30

140.64%

Overvalued

-50.72

Trailing

Forward

67.06

EV/EBITDA

AngioDynamics Inc. (ANGO) has a current EV/EBITDA of 67.06. The 5-year average EV/EBITDA is -8.30. The thresholds are as follows: Strongly Undervalued below -381.15, Undervalued between -381.15 and -194.73, Fairly Valued between 178.12 and -194.73, Overvalued between 178.12 and 364.54, and Strongly Overvalued above 364.54. The current Forward EV/EBITDA of 67.06 falls within the Historic Trend Line -Fairly Valued range.

-33.59

EV/EBIT

AngioDynamics Inc. (ANGO) has a current EV/EBIT of -33.59. The 5-year average EV/EBIT is 296.47. The thresholds are as follows: Strongly Undervalued below -2144.15, Undervalued between -2144.15 and -923.84, Fairly Valued between 1516.78 and -923.84, Overvalued between 1516.78 and 2737.09, and Strongly Overvalued above 2737.09. The current Forward EV/EBIT of -33.59 falls within the Historic Trend Line -Fairly Valued range.

12.30

AngioDynamics Inc. (ANGO) has a current PS of 12.30. The 5-year average PS is 1.91. The thresholds are as follows: Strongly Undervalued below -0.88, Undervalued between -0.88 and 0.51, Fairly Valued between 3.30 and 0.51, Overvalued between 3.30 and 4.69, and Strongly Overvalued above 4.69. The current Forward PS of 12.30 falls within the Strongly Overvalued range.

0.00

P/OCF

AngioDynamics Inc. (ANGO) has a current P/OCF of 0.00. The 5-year average P/OCF is -17.31. The thresholds are as follows: Strongly Undervalued below -357.94, Undervalued between -357.94 and -187.62, Fairly Valued between 153.00 and -187.62, Overvalued between 153.00 and 323.31, and Strongly Overvalued above 323.31. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/FCF

AngioDynamics Inc. (ANGO) has a current P/FCF of 0.00. The 5-year average P/FCF is -8.37. The thresholds are as follows: Strongly Undervalued below -92.23, Undervalued between -92.23 and -50.30, Fairly Valued between 33.57 and -50.30, Overvalued between 33.57 and 75.50, and Strongly Overvalued above 75.50. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

AngioDynamics Inc (ANGO) has a current Price-to-Book (P/B) ratio of 2.93. Compared to its 3-year average P/B ratio of 1.43 , the current P/B ratio is approximately 104.81% higher. Relative to its 5-year average P/B ratio of 1.66, the current P/B ratio is about 76.94% higher. AngioDynamics Inc (ANGO) has a Forward Free Cash Flow (FCF) yield of approximately -0.03%. Compared to its 3-year average FCF yield of -5.32%, the current FCF yield is approximately -99.38% lower. Relative to its 5-year average FCF yield of -3.34% , the current FCF yield is about -99.02% lower.

2.85

P/B

Median3y

1.43

Median5y

1.66

-0.03

FCF Yield

Median3y

-5.32

Median5y

-3.34

Competitors Valuation Multiple

The average P/S ratio for ANGO's competitors is 11.10, providing a benchmark for relative valuation. AngioDynamics Inc Corp (ANGO) exhibits a P/S ratio of 12.30, which is 10.83% above the industry average. Given its robust revenue growth of 12.18%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

Pacific Biosciences of California Inc

Performance Decomposition

Market capitalization of ANGO increased by 77.49% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -8.29 to -15.70.

The secondary factor is the Revenue Growth, contributed 12.18%to the performance.

Overall, the performance of ANGO in the past 1 year is driven by P/E Change. Which is more unsustainable.

12.18%

67.49M → 75.71M

Revenue Growth

-24.05%

-18.96 → -14.40

Margin Expansion

89.36%

-8.29 → -15.70

P/E Change

77.49%